Your Definitive Guide to Ensuring Peak Performance of Your Pharmacy Program Managing the pharmacy program has never been more complex for plan sponsors. Innovative drugs…
Today is a milestone in the world of biosimilars, as the first Humira® biosimilar Amjevita™ (adalimumab-atto), manufactured by Amgen, has launched in the U.S. Will it have…
CVS Health (CVS) announced their 2022 formulary changes, both exclusions and additions, stating the focus of their formulary strategy continues to be “providing access to…
In recent weeks, Express Scripts (ESI) released their list of January 1, 2022 formulary changes for their National Preferred Formulary and National Preferred Flex Formulary.
Join the discussion already in progress as we shift gears from last week’s installment on “Unpacking utilization and medical pharmacy integration” to this week’s…
Thinking back to one year ago, when writing this commentary on the upcoming 2020 formulary changes, no one could have foreseen the challenges and difficulties…